Field Safety Notices about Ellipse DR, VR

According to ALIMS (Agencija za lekove i medicinska sredstva), this field safety notices involved a device in Serbia that was produced by St Jude Medical Operations.

What is this?

Field safety notices are communications sent out by medical device manufacturers or their representatives in relation to actions that they may be taking in relation to their product that is on the market. These are mainly for health workers, but also for users. They can include recalls and alerts.

Learn more about the data here
  • Type of Event
    Field Safety Notice
  • Date
  • Event Date Posted
  • Event Country
  • Event Source
  • Event Source URL
  • Notes / Alerts
    Serbian data is current through February 2018. All of the data comes from ALIMS (Agencija za lekove i medicinska sredstva), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Serbia.
  • Extra notes in the data
  • Reason
    According to the report of the manufacturer, during the maintenance of the condenser or during charging for the high-voltage therapy of the active implantable medical device "st. jude medical ellipse vr / dr - implantable cardioverter defibrillator (icd), the message "capacitor charge time limit reached" may appear due to a fault with the high voltage capacitor. this error may delay the delivery of high-voltage therapy or suspend delivery of part or all of the programmed high-voltage shocks. as a result of this error, there were no serious injuries or deaths reported to "st. jude medical. ".


  • Model / Serial
    model numbers „CD1277“, „CD1377“, „CD2277“, „CD2377“ ending with „-36, -36Q, -36C i -36QC“ - all lots
  • Manufacturer


  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source